Walgreens Boots Alliance, Inc. to Issue Quarterly Dividend of $0.25 (NASDAQ:WBA)

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) declared a quarterly dividend on Thursday, October 24th, RTT News reports. Shareholders of record on Monday, November 18th will be paid a dividend of 0.25 per share by the pharmacy operator on Thursday, December 12th. This represents a $1.00 dividend on an annualized basis and a yield of 10.80%.

Walgreens Boots Alliance has raised its dividend payment by an average of 1.3% annually over the last three years. Walgreens Boots Alliance has a dividend payout ratio of 59.9% indicating that its dividend is sufficiently covered by earnings. Analysts expect Walgreens Boots Alliance to earn $1.58 per share next year, which means the company should continue to be able to cover its $1.00 annual dividend with an expected future payout ratio of 63.3%.

Walgreens Boots Alliance Stock Down 0.9 %

NASDAQ:WBA opened at $9.26 on Friday. The firm has a market capitalization of $7.99 billion, a P/E ratio of -1.37, a PEG ratio of 1.24 and a beta of 0.70. Walgreens Boots Alliance has a 1-year low of $8.22 and a 1-year high of $27.05. The company’s fifty day moving average price is $9.34 and its 200-day moving average price is $12.88. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.68 and a quick ratio of 0.37.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.03. The firm had revenue of $37.50 billion for the quarter, compared to analyst estimates of $35.75 billion. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The business’s quarterly revenue was up 5.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.67 earnings per share. As a group, equities research analysts anticipate that Walgreens Boots Alliance will post 1.57 EPS for the current year.

Analysts Set New Price Targets

Several research firms recently commented on WBA. Morgan Stanley dropped their price target on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating on the stock in a research report on Friday, October 11th. UBS Group increased their price objective on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a report on Thursday, October 17th. Jefferies Financial Group decreased their price objective on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a report on Wednesday. Evercore ISI raised their price target on shares of Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an “in-line” rating in a research note on Wednesday, October 16th. Finally, TD Cowen decreased their price target on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a research note on Tuesday. Four equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $12.88.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.